- Display 30 Products per page
Published: December 17, 2014 | Price: $995.00 – $1,990.00
Ultrasound: World Market Analysis Medical imaging has led to improvements in the diagnosis and treatment of numerous medical conditions in children and adults. There are many types of medical imaging procedures, each of which uses different technologies and techniques. Ultrasound is defined as energy generated by sound waves of 20,000 or more vibrations per second, with a frequency greater than the upper limit of the human hearing range. Knowledge of the harmful effects of radiation exposure continues to promote the...Published: March 27, 2018 | Price: $995.00 – $1,990.00
Mergers and Acquisitions in the IVD Market Mergers and Acquisitions in the IVD Market records over 220 acquisitions in the in vitro diagnostics (IVD) industry in total, featuring approximately 152 purchase arrangements in 2015-2016 and 69 acquisitions in IVD and related segments so far from 2017 to March 2018. Among the leading diagnostics companies looking to increase market share and produce revenue growth via acquisition are Abbott/Alere, Beckman Coulter / Danaher, and Roche. Abbott's acquisition of Alere and related divestures...Published: October 17, 2018 | Price: $1,000.00 – $2,000.00
Presents Kalorama’s estimates of histology and cytology procedures, 2016-2021.Published: October 1, 2006 | Price: $1,200.00 – $5,990.00
Ultrasound, also known as sonography, is not a new imaging modality—having been around since the 1950s—but its application areas have just recently begun to expand tremendously. These new clinical applications, along with technological innovations in portability and resolution and a very favorable risk profile, have made ultrasound equipment a very robust market sector. This third volume in Kalorama’s ongoing series on medical imaging examines the market for ultrasound equipment worldwide, reviewing the drivers and restraints, the established and emerging application...Published: December 6, 2017 | Price: $1,200.00 – $2,400.00
Human Microbiome Applications in IVD and Other Healthcare Human Microbiome Applications in IVD and Other Healthcare examines the growing interest in the human microbiome in in vitro diagnostics and other healthcare applications. This report notes IVD company interest in the microbiome, including selected microbiome-based tests, including selected molecular tests; microbiome-based diagnostic biomarkers; and precision or personalized medicine approaches to the microbiome. Human Microbiome Applications in IVD and Other Healthcare notes pharmaceutical company interest in the microbiome as well. Discussed are...Published: October 1, 2003 | Price: $1,496.00 – $2,992.00
Diagnostic testing for prion diseases has become more important as countries increase the number of tests to battle the potential public health problem. Academic, government, and industry organizations continue to develop diagnostic testing technologies and policies as preventative measures. The number of prion diagnostic technologies being used and developed for prion diseases primarily reflects the scientific and technical challenges of detecting prion proteins. Growth of prion testing will depend on these technology breakthroughs and the future prevalence of prion disease....Published: December 1, 2003 | Price: $1,496.00 – $2,992.00
Severe Acute Respiratory Syndrome (SARS), which was a new and unidentified disease when it first affected people, ripped through Asia and Toronto from late 2002 into the summer of 2003, before being contained for the season. Taiwan with just 346 reported cases performed 10,000 diagnostic tests. Three years after West Nile Virus (WNV) first appeared in the United States in 1999 with just 62 cases and 7 deaths, the U.S. Center for Disease Control reports thousands of cases and 150...Published: November 1, 2006 | Price: $1,500.00 – $5,990.00
This report takes a bold look into the markets, technologies, and trends in decentralized testing with a special focus on the economics of rapid test use in critical care and emergency medicine. There is also an emphasis on early disease detection via rapid test use in clinics and public venues. The report is conservative in its predictions and offers a calculated look into the future, based on events currently taking place. The field for rapid test devices is crowded; worldwide,...Published: August 1, 2008 | Price: $1,500.00 – $7,000.00
The benefits of automation in the clinical laboratory are well documented. They involve replacing manual, potentially dangerous, error-prone steps with automated processes requiring minimal operator intervention. This approach can increase productivity, decrease turnaround time, improve staff safety, minimize errors, improve the handling of specimens, and allow labs to reallocate personnel to more important and productive tasks. For drug discovery, automation also offers benefits. bringing a new drug to market has been both a very time-intensive, laborious and expensive undertaking. This...Published: August 1, 2008 | Price: $1,500.00 – $7,000.00
Test services, once the norm in the diagnostics industry, then abandoned for reagent sales, are now making a comeback. IVD companies have established cGMP and CLIA-registered labs by which they offer their proprietary tests to physicians, hospitals and reference labs. These tests are outside the oversight of the traditional FDA and CE Mark test commercialization avenue in the U.S, and Europe and so are thought to come to market by what may seem to be the back door. Kalorama has...Published: February 1, 2009 | Price: $1,500.00 – $7,000.00
The reinvigorated market for medical imaging systems employing x-rays has undoubtedly been propelled by the explosion of digital technology. But also, the expanded role of imaging modalities in a whole host of clinical applications from trauma to cancer to cardiology has increased the profile of radiography while enabling computer technologies expand the usefulness of traditional x-ray techniques. Kalorama's Medical Imaging Markets Volume I: Radiography analyzes the current and potential world market for medical x-ray systems, including several distinct imaging modalities...Published: April 1, 2009 | Price: $1,500.00 – $9,990.00
From Kalorama Information a unique tool for assessing the diagnostic business today. Working in conjunction with premier diagnostic survey database Emmes Group, Kalorama Information presents the summarized results from a recent survey of a critical mass of diagnostic labs in the U.S, with analysis from Kalorama's leading diagnostic analyst, Shara Rosen. Far more than any other market research report, this report provides the most current and accurate picture of what is truly going on in molecular diagnostics in the United...Published: March 1, 2011 | Price: $1,500.00 – $2,500.00
This bundle provides customers with three of the most intensely researched Kalorama Information reports covering the diagnostic industry authored by Shara Rosen, R.T., M.B.A. in 2010 and 2011 These reports will be provided in one PDF, each with its own table of contents. The bundle allows customers to save almost $4,500 off the cost of the individual reports. THE WORLDWIDE MARKET FOR IN VITRO DIAGNOSTIC TESTS, 7th Edition This 900 page report contains coverage of all segments of In Vitro...Published: September 13, 2013 | Price: $1,500.00 – $3,000.00
Brazil is the fifth largest country in the world, after Russia, Canada, China and the United States. The size of the country as made it a focus for IVD companies. This report, The IVD Market in Brazil, provides market estimates and forecasts for the main categories of in vitro diagnostics, and forecasts those markets to 2017. Information was obtained by both primary and secondary sources. Annual reports, trade publications, as well as telephone and email surveys of IVD manufacturers operating...Published: March 21, 2018 | Price: $1,500.00 – $3,000.00
This report provides market estimates and forecasts for point-of-care glucose testing. Information in this report is from the latest published figures for companies participating in the market as well as recent interviews. The following markets analysis is provided in this report: Global POC Glucose Testing Market Analysis, 2015-2022 (in millions of dollars at the manufacturer’s level) POC Blood Glucose Testing Regional Market Analysis, 2017 (US, Europe, Asia, ROW) Global POC Glucose Self-Testing Market (includes continuous glucose devices) ...Published: March 28, 2018 | Price: $1,500.00 – $3,000.00
Convenience clinics are designed to occupy small spaces and provide just basic care. Therefore, they do not use most of the sophisticated medical equipment found in hospitals or specialty centers such as advanced imaging devices. In fact, while a few larger centers have x-ray machines, most do not. However, retail clinics are becoming relatively large users of point-of-care (POC) tests, clinical chemistry and immunoassay laboratory tests and vaccines. This chapter examines the effect of retail clinics on each of these...Published: October 25, 2018 | Price: $1,500.00 – $3,000.00
This brief report contains Kalorama Information's estimates of European in vitro diagnostics markets including current (2018) country level estimates and forecasts. Content for this report is based on information in The Worldwide Market for In Vitro Diagnostic Tests, 11th Edition, with additional forecasting information.Published: November 1, 2008 | Price: $1,990.00 – $2,000.00
This report takes a bold look into the world glucose testing, ten years from now. It is not an exercise in crystal ball gazing. Rather, in this report, Kalorama offers a calculated look into the future, based on events taking place in the present. The report offers a quantitative assessment of specific markets, worldwide, in US dollars for 2007 to 2012. With the reported growing epidemic of diabetes, worldwide, it is widely held that glucose self testing and diabetes management...Published: April 1, 2004 | Price: $1,995.00 – $3,990.00
The recent terrorism events, in addition to the ease of travel that allows infectious diseases to spread, and technology developments drive the renewed interest in clinical and environmental infectious disease diagnostics. The combined public health and bio-terrorism markets of several bacterial and protozoan diseases are estimated to be nearly $100 million. This report, the final volume of the Diagnostics for Emerging Infectious Disease Threats series, focuses on diagnostic testing for 11 bacterial and protozoal diseases in clinical and environmental testing:...Published: September 1, 2006 | Price: $1,995.00 – $7,800.00
This comprehensive evaluation of the blood industry provides an analysis of all the key market segments involved in this industry, including blood products such as: Red Blood Cells (RBCs) Immunoglobulins Albumin Other Plasma Products Synthetic HBOC and PFC Agents Recombinant Factors And blood supply management products, including: Blood Collection Equipment Automated Blood Collection Equipment Blood Banking and Plasmapheresis Testing Blood Typing Human Immunodeficiency Virus (HIV) Testing Hepatitis A Virus Testing Hepatitis B Virus Testing Hepatitis C Virus Testing Human T-Cell...Published: February 1, 2007 | Price: $1,995.00 – $5,990.00
Contrast agents and radiopharmaceuticals have revolutionized in vivo imaging. Technical developments in contrast media and imaging techniques is combining with the trends toward both the functional and molecular understanding of disease to create a rapidly growing marketplace in these agents. The introduction and now brisk ongoing development of contrast media for traditional radiography, computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, positron-emission tomography (PET), and single-photon emission computed tomography (SPECT), are now allowing for the expansion of diagnostic capabilities of...Published: February 1, 2007 | Price: $1,995.00 – $3,990.00
Lateral flow tests, also known as immunochromatographic strip (ICS) tests, offer dramatic benefits in the diagnostic process that point towards a robust market. LF tests are point of care tests that reduce the time spent waiting for test results from hours to minutes, require less training for operators, and reduce the cost of both device development and manufacturing. Rapid point of care testing devices will play an increasingly important role in the decentralization of medicine, where testing is moving away...Published: November 1, 2007 | Price: $1,995.00 – $3,990.00
No longer is cell-based diagnostics simply a histological study of biopsied and surgical tissues. Combinations of tests and technologies are coming together to create a new map of cell diagnostics. Image cytometry, microfluidics, microarrays, and biosensors, special immunohistochemical and in situ hybridization probes are creating new approaches to cell and tissue observation, diagnostics and pharmacogenomics. This report covers assay systems that use cells as the basic source material. Sources of the cells to be studied include peripheral blood, cord blood,...Published: November 1, 2010 | Price: $1,995.00 – $3,990.00
Physician Office Laboratory (POL) Testing Markets Worldwide: Status Quo and Future Trends The physician office laboratory (POL) is usually not broken out in market research reports covering the medical device and diagnostic industry. Numbers are often simply grouped in with hospital and service lab sales. But for marketing strategy, knowing where diagnostic tests occur is as important as the revenue numbers. Now, Kalorama Information shines further light onto the POL testing market with its report, Physician office Laboratory (POL) Testing...Published: January 1, 2012 | Price: $1,995.00 – $4,995.00
This Kalorama Information report - The World Market for Cancer Therapeutics and Biotherapeutics (Chemotherapy Agents, Interleukins/interferons, Monoclonal Antibodies, Hormone and Other Therapies) represents the fourth time that Kalorama Information has taken a comprehensive look at oncology therapeutics. The report focuses on several segments for cancer treatment including: Chemotherapy, - Subcategories include Alkylating Agents, Antimetabolites, Cytotoxic Agents, Plant Derivatives - Brands such as Elotaxin, Taxotere, Gemzar, Alimta and Temodar, with Market Share for each Hormone Therapy: - Subcategories include Corticosteroids, Hormone...Published: June 15, 2012 | Price: $1,995.00 – $3,990.00
Veterinary diagnostics have incorporated technologies and methods gained from human diagnostics and mainstream healthcare to develop a now full-fledged sister market that remains open to further innovation. Major diagnostic methods in mainstream healthcare – immunodiagnostics, molecular testing (including nucleic acid testing), hematology and clinical chemistry – now have standard applications in the veterinary care of companion (pets) and food animals (livestock and production animals). This report, The World Market for Veterinary Diagnostics, looks at these trends and details: Markets for Consumer Animal...Published: December 6, 2012 | Price: $1,995.00 – $8,400.00
The World Market for Point of Care (POC) Diagnostics Visit our 'Point of Care Testing' curated page for complete industry coverage. Point-of-care (POC) tests are diagnostic tests that are performed at or near the site where the patient is located. They are performed in decentralized settings, outside of central hospital laboratories or centralized reference laboratories. Growth in POC testing is being fueled by many factors including the growing number of people with diabetes, the globalization of infectious diseases and the...Published: January 31, 2013 | Price: $1,995.00 – $3,990.00
IVD Procedure Volume and Pricing Analysis This report examines the global procedure volumes for IVD and laboratory tests. It covers only commercialized tests, specifically excluding those that are developmental or used primarily for research purposes.. Point of Care (Glucose, Pregnancy, Other) CoreLab (General Chemistries, Blood Gas Analyzers, Urinalysis, Immunoassays Infectious Disease, Cardiac Markers, Diabetes/HbA1c, Autoimmune) Molecular (Infectious Disease [inc. molecular tests for HIV, Hepatitis, STDs, HAI, Respiratory, Other], Oncology, Inherited Disease, Other) Hematology Coagulation (PT, PTT) Microbiology (Automated Panels, Manual...Published: August 5, 2013 | Price: $1,995.00 – $3,990.00
Australia represents a highly competitive IVD market with established international players, a highly developed export-intensive domestic industry, and highly consolidated clinical lab and testing industry. While other developed IVD markets in North America, Europe and Japan are not estimated to be achieving above 3% annual growth, the Australian IVD market has grown at an average of roughly 5% through the past five years. This rate of growth is projected to more or less continue with a stable funding environment through...Published: October 25, 2013 | Price: $1,995.00 – $3,900.00
What is the procedure, for establishing reimbursement for an IVD test product? What companies have been successful and how? What changes will IVD makers face in the near-term. This Kalorama Information report, Reimbursement for In Vitro Diagnostic Tests, answers these questions and provides authoritative data for IVD business planners. One of the critical factors for the success of an IVD product is reimbursement. Reimbursement is a critical component of the health care landscape and will continue to have a major...